Cover Image
市場調查報告書

免疫血液學市場分析:各產品 (分析儀、試劑)、各最終用途 (醫院、血庫、診斷測試所)、各地區的市場區隔預測

Immunohematology Market Analysis by Product (Immunohematology Analyzer, Immunohematology Reagent), By End Use (Hospitals, Blood banks, Diagnostic Laboratories), By Region (North America, Europe, APAC, LATAM & MEA) And Segment Forecasts, 2013 - 2024

出版商 Grand View Research, Inc. 商品編碼 408965
出版日期 內容資訊 英文 120 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
免疫血液學市場分析:各產品 (分析儀、試劑)、各最終用途 (醫院、血庫、診斷測試所)、各地區的市場區隔預測 Immunohematology Market Analysis by Product (Immunohematology Analyzer, Immunohematology Reagent), By End Use (Hospitals, Blood banks, Diagnostic Laboratories), By Region (North America, Europe, APAC, LATAM & MEA) And Segment Forecasts, 2013 - 2024
出版日期: 2016年12月01日 內容資訊: 英文 120 Pages
簡介

本報告提供全球免疫血液學市場相關調查,市場趨勢,各產品、各最終用途、各地區趨勢,及打入市場的主要企業簡介等彙整資料。

第1章 調查方法

第2章 摘要整理

第3章 市場變動,趨勢,範圍

  • 市場區隔和範圍
    • 促進要素分析
    • 阻礙要素分析
  • 滲透、成長預測製圖
  • 產業分析:波特
  • 競爭環境

第4章 各產品預測、趨勢分析

  • 各產品趨勢分析
  • 分析儀
  • 試劑

第5章 各最終用途預測、趨勢分析

  • 各最終用途趨勢分析
  • 醫院
  • 血庫
  • 診斷測試所

第6章 各地區預測、趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第7章 競爭環境

  • 策略架構
  • 企業簡介
目錄
Product Code: GVR-1-68038-302-7

The global immunohematology market is expected to reach a value of USD 2.3 billion by 2024, according to a new report by Grand View Research, Inc. This expansion is attributed to the increasing cases of trauma and rising number of hospital and trauma care centers facilitating emergency treatments. This creates a need to procure blood to suffice the demand, thus, boosting the market for immunohematology tests and products.Involvement of government organizations and NGOs is vast in this field.

Use of technology is contributing to the growth in the market. Use of mobile applications helps in tracking the blood donation activity of volunteer donors and also reminds them to donate regularly. In April 2016, The Indian Red Cross Society launched an application (app) to facilitate blood banking facility. The app is expected to address the shortage issue in the region. Moreover, in 2011, the first type of this application was launched by Hemo bioscience, Inc., a U.S.-based company. The company made the app available for free for apple users.

Further Key Findings From the Study Suggest:

  • Immunohematology reagents dominated the product segment in 2015 due to huge product variety and an increasing number of blood banks procuring these reagents. The innovations in the field are resulting in new product launches and also the efforts are acknowledged at a global level.
  • In December 2013, Sysmex Corporation received the German Design Award for its XN-2000 hematology reagent. Almost 1,900 products were nominated for the award.
  • Hospitals dominated the end-use segment in 2015 due to increasing number of emergency cases because of road accidents and other types of trauma. Governments and investors are increasingly investing in expanding and upgrading emergency departments in hospitals to cater to the growing demand and increase the chances of survival of trauma patients.
  • In 2015, North America dominated the market with a revenue share of more than 40%. In the U.S., there is a patient requiring transfusion every 2 seconds. The daily consumption of blood is approximately 36,000 units per day. This indicates the huge opportunity of growth in this region.
  • Some of the key industry players are Hologic, Inc., Bio-Rad Laboratories, Inc.; Grifols, ThermoFisher, Immucor; Ortho Clinical Diagnostics; BD (Becton Dickinson); Siemens Healthcare GmbH; Abbott; and Beckman Coulter, Inc.

Table of Content

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Market Variables, Trends& Scope

  • 3.1 Market Segmentation and Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Increasing rate of trauma injuries
      • 3.1.1.2 Industry players introducing new products
      • 3.1.1.3 Rising prevalence of target diseases
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 High cost of products
  • 3.2 Penetration & Growth Prospects Mapping
  • 3.3 Immunohematology Market - PESTLE Analysis
  • 3.4 Industry Analysis - Porter's
  • 3.5 Competitive landscape: Market position analysis (based on products, regional presence and strategic initiatives)

Chapter 4 Immunohematology Market Product Estimates & Trend Analysis

  • 4.1 Immunohematology Market: Product Movement Analysis
  • 4.2 Immunohematology analyzer
    • 4.2.1 Immunohematology analyzer market estimates and forecasts, 2013 - 2024 (USD Million)
  • 4.3 Immunohematology reagent
    • 4.3.1 Immunohematology reagent market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 5 Immunohematology Market End-Use Estimates & Trend Analysis

  • 5.1 Immunohematology Market: End-Use Movement Analysis
  • 5.2 Hospitals
    • 5.2.1 Hospitals market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.3 Blood banks
    • 5.3.1 Blood banks market estimates and forecasts, 2013 - 2024 (USD Million)
  • 5.4 Diagnostic laboratories
    • 5.4.1 Diagnostic laboratories market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 6 Immunohematology Market: Regional Estimates & Trend Analysis

  • 6.1 Regional Movement Analysis & Market Share, 2015 & 2024
  • 6.2 North America
    • 6.2.1 North America immunohematology market, by product, 2013 - 2024 (USD Million)
    • 6.2.2 North America immunohematology market, by end-use, 2013 - 2024 (USD Million)
    • 6.2.3 U.S.
      • 6.2.3.1 U.S. immunohematology market, by product, 2013 - 2024 (USD Million)
      • 6.2.3.2 U.S. immunohematology market, by end-use, 2013 - 2024 (USD Million)
    • 6.2.4 Canada
      • 6.2.4.1 Canada immunohematology market, by product, 2013 - 2024 (USD Million)
      • 6.2.4.2 Canada immunohematology market, by end-use, 2013 - 2024 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe immunohematology market, by product, 2013 - 2024 (USD Million)
    • 6.3.2 Europe immunohematology market, by end-use, 2013 - 2024 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany immunohematology market, by product, 2013 - 2024 (USD Million)
      • 6.3.3.2 Germany immunohematology market, by end-use, 2013 - 2024 (USD Million)
    • 6.3.4 UK
      • 6.3.4.1 UK immunohematology market, by product, 2013 - 2024 (USD Million)
      • 6.3.4.2 UK immunohematology market, by end-use, 2013 - 2024 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific immunohematology market, by product, 2013 - 2024 (USD Million)
    • 6.4.2 Asia Pacific immunohematology market, by end-use, 2013 - 2024 (USD Million)
    • 6.4.3 Japan
      • 6.4.3.1 Japan immunohematology market, by product, 2013 - 2024 (USD Million)
      • 6.4.3.2 Japan immunohematology market, by end-use, 2013 - 2024 (USD Million)
    • 6.4.4 China
      • 6.4.4.1 China immunohematology market, by product, 2013 - 2024 (USD Million)
      • 6.4.4.2 China immunohematology market, by end-use, 2013 - 2024 (USD Million)
    • 6.4.5 India
      • 6.4.5.1 India immunohematology market, by product, 2013 - 2024 (USD Million)
      • 6.4.5.2 India immunohematology market, by end-use, 2013 - 2024 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America immunohematology market, by product, 2013 - 2024 (USD Million)
    • 6.5.2 Latin America immunohematology market, by end-use, 2013 - 2024 (USD Million)
    • 6.5.3 Brazil
      • 6.5.3.1 Brazil immunohematology market, by product, 2013 - 2024 (USD Million)
      • 6.5.3.2 Brazil immunohematology market, by end-use, 2013 - 2024 (USD Million)
    • 6.5.4 Mexico
      • 6.5.4.1 Mexico immunohematology market, by product, 2013 - 2024 (USD Million)
      • 6.5.4.2 Mexico immunohematology market, by end-use, 2013 - 2024 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA immunohematology market, by product, 2013 - 2024 (USD Million)
    • 6.6.2 MEA immunohematology market, by end-use, 2013 - 2024 (USD Million)
    • 6.6.3 South Africa
      • 6.6.3.1 South Africa immunohematology market, by product, 2013 - 2024 (USD Million)
      • 6.6.3.2 South Africa immunohematology market, by end-use, 2013 - 2024 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Strategy framework
  • 7.2 Company Profiles
  • 7.3 Bio-Rad Laboratories, Inc.
    • 7.3.1 Company overview
    • 7.3.2 Financial performance
    • 7.3.3 Product benchmarking
    • 7.3.4 Strategic initiatives
  • 7.4 Immucor
    • 7.4.1 Company overview
    • 7.4.2 Financial performance
    • 7.4.3 Product benchmarking
    • 7.4.4 Strategic initiatives
  • 7.5 Grifols
    • 7.5.1 Company overview
    • 7.5.2 Financial performance
    • 7.5.3 Product benchmarking
    • 7.5.4 Strategic initiatives
  • 7.6 BD (Becton Dickinson)
    • 7.6.1 Company overview
    • 7.6.2 Financial performance
    • 7.6.3 Product benchmarking
    • 7.6.4 Strategic initiatives
  • 7.7 Hologic, Inc.
    • 7.7.1 Company overview
    • 7.7.2 Financial performance
    • 7.7.3 Product benchmarking
    • 7.7.4 Strategic initiatives
  • 7.8 Siemens Healthcare GmbH
    • 7.8.1 Company overview
    • 7.8.2 Financial performance
    • 7.8.3 Product benchmarking
    • 7.8.4 Strategic Initiatives
  • 7.9 ThermoFisher
    • 7.9.1 Company overview
    • 7.9.2 Financial performance
    • 7.9.3 Product benchmarking
    • 7.9.4 Strategic initiatives
  • 7.10 Abbott
    • 7.10.1 Company overview
    • 7.10.2 Financial performance
    • 7.10.3 Product benchmarking
    • 7.10.4 Strategic initiatives
  • 7.11 Beckman Coulter, Inc.
    • 7.11.1 Company overview
    • 7.11.2 Financial performance
    • 7.11.3 Product benchmarking
    • 7.11.4 Strategic initiatives
  • 7.12 Roche Diagnostics Corporation
    • 7.12.1 Company overview
    • 7.12.2 Financial performance
    • 7.12.3 Product benchmarking
    • 7.12.4 Strategic initiatives

List of Tables

  • TABLE 1 Immunohematology - global market current and forecast by regions (2015-2024) in (USD Million)
  • TABLE 2 North America immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
  • TABLE 3 North America immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 4 North America immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 5 U.S. immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 6 U.S. immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 7 Canada immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 8 Canada immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 9 Europe immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
  • TABLE 10 Europe immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 11 Europe immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 12 UK immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 13 UK immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 14 Germany immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 15 Germany immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 16 Asia Pacific immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
  • TABLE 17 Asia Pacific immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 18 Asia Pacific immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 19 Japan immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 20 Japan immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 21 China immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 22 China immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 23 India immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 24 India immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 25 Latin America immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
  • TABLE 26 Latin America immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 27 Latin America immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 28 Brazil immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 29 Brazil immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 30 Mexico immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 31 Mexico immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 32 MEA immunohematology market estimates and forecasts, by country, 2013 - 2024 (USD Million)
  • TABLE 33 MEA immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 34 MEA immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)
  • TABLE 35 South Africa immunohematology market estimates and forecasts, by product, 2013 - 2024 (USD Million)
  • TABLE 36 South Africa immunohematology market estimates and forecasts, by end-use, 2013 - 2024 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value Chain Based Sizing & Forecasting
  • FIG. 6 QFD Modeling For Market Share Assessment
  • FIG. 7 Market Summary
  • FIG. 8 Market Trends & Outlook
  • FIG. 9 Market Segmentation & Scope
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 Penetration & Growth Prospect Mapping
  • FIG. 13 Immunohematology market - PESTLE Analysis
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Immunohematology market product outlook key takeaways
  • FIG. 16 Immunohematology market: Product movement analysis
  • FIG. 17 Global immunohematology market, by product 2013 - 2024 (USD Million)
  • FIG. 18 Global immunohematology analyzer market, 2013 - 2024 (USD Million)
  • FIG. 19 Global immunohematology reagent market, 2013 - 2024 (USD Million)
  • FIG. 20 Global immunohematology market, by end-use, 2013 - 2024 (USD Million)
  • FIG. 21 Global hospital market, 2013 - 2024 (USD Million)
  • FIG. 22 Global blood bank market, 2013 - 2024 (USD Million)
  • FIG. 23 Global diagnostic laboratories market, 2013 - 2024 (USD Million)
  • FIG. 24 Regional market place: Key takeaways
  • FIG. 25 Immunohematology market regional outlook, 2015 & 2024
  • FIG. 26 North America immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 27 U.S. immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 28 Canada immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 29 Europe immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 30 Germany immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 31 UK immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 32 Asia Pacific immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 33 Japan immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 34 China immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 35 India immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 36 Latin America immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 37 Brazil immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 38 Mexico immunohematology market, 2013 - 2024 (USD Million
  • FIG. 39 Middle East immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 40 South Africa immunohematology market, 2013 - 2024 (USD Million)
  • FIG. 41 Strategy framework
Back to Top